Accessibility Menu
Evome Medical Technologies logo

Evome Medical Technologies(OTC) LNDZF

Current Price$0.00
Market Cap$100.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2015)-100%
5 Year-100%
1 Year-100%
1 Month+0%
Evome Medical Technologies last closing stock price
MetricPriceDate
Last closeUSD 0.002026-05-04
Evome Medical Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-02-20
1 month+0%USD 0.002026-02-20
3 month+0%USD 0.002025-12-04
Year to date+0%USD 0.002025-12-04
1 year-99.97%USD 0.002025-04-22
3 year-100%USD 0.262023-05-04
5 year-100%USD 0.132020-08-21
Since inception-100%USD 0.982015-09-17

Evome Medical Technologies Financials at a Glance

Market Cap

$100.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$48.34M

Net Income (TTM)

-CA$23.53M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

864.03 (High)

Price

$0.00

Volume

10,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Jul 22, 2026

LNDZF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Evome Medical Technologies

Evome Medical Technologies Inc. is a global company that conceives, produces, and markets medical equipment across the Americas and other international markets. The firm's diverse array of products is primarily focused on pain alleviation and physical restoration therapies.

Products and Services
  • Specialized instruments for measuring muscle strength
  • Advanced systems for gait training and balance evaluation
  • Wearable technologies and electrical stimulation devices
Growth Outlook
  • Revenue of CAD 10,011,091 in Q3 2024, showing consistent demand
  • Gross profit margin improved to 35.58% in Q3 2024
  • Positive net income of CAD 2,988,468 in Q3 2023 indicates potential for profitability
Financial Highlights
  • Trailing twelve months (TTM) revenue of CAD 39,000,000
  • Operating income of CAD 97,250 in Q3 2024, a significant improvement
  • Cash flow from operations of CAD 1,785,943 in Q3 2024
Evome Medical Technologies Inc. operates in the medical devices sector, focusing on innovative solutions for pain management and rehabilitation. The company has demonstrated a strong revenue trajectory, with a notable increase in gross profit margins, reflecting effective cost management and product demand. The recent quarterly results indicate a shift towards profitability, with a positive net income reported in Q3 2023. The cash flow from operations has also shown improvement, suggesting a healthier financial position. With a diverse product portfolio and a commitment to enhancing human health, Evome Medical Technologies Inc. presents an intriguing opportunity for potential investors.
AI Generated • Jun 28, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

205

CEO

Michael D. Seckler

Website

www.evomemedical.com

Headquarters

Shirley, NY 92014, US

LNDZF Financials

Key Financial Metrics (TTM)

Gross Margin

32.56%

Operating Margin

-24.30%

Net Income Margin

-23.87%

Return on Equity

-44.17%

Return on Capital

-19.24%

Return on Assets

-10.24%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$100.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

60.17M

Volume

10.00K

Avg. Volume

161.29

Financials (TTM)

Gross Profit

CA$16.34M

Operating Income

-CA$5.50M

EBITDA

-CA$16.11M

Operating Cash Flow

CA$5.40M

Capital Expenditure

-CA$36.08K

Free Cash Flow

CA$5.37M

Cash & ST Invst.

CA$1.41M

Total Debt

CA$17.47M

Evome Medical Technologies Performance Analysis

Evome Medical Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-02-28CAD 14,583,414N/A
20232023-12-31CAD 46,401,464218.2%
Evome Medical Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-31-20.0%
Q12024-03-31-23.2%
Q22024-06-30-12.7%
Q32024-09-30-5.0%
Evome Medical Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-02-28CAD -0.08N/A
20232023-12-31CAD -0.1696.6%
Evome Medical Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-31-764.7%
Q12024-03-3176.1%
Q22024-06-3040.0%
Q32024-09-3066.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

CA$10.01M

-49.0%

Gross Profit

CA$3.56M

-51.0%

Gross Margin

35.58%

N/A

Market Cap

$100.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$0.51

N/A

Employees

195

N/A

Net Income

-CA$1.15M

-138.5%

EBITDA

CA$1.16M

-76.0%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Total Cash

CA$1.41M

+34.3%

Total Debt

CA$17.47M

-35.7%

Accounts Receivable

CA$6.74M

-44.7%

Inventory

CA$9.26M

-23.7%

Long Term Debt

CA$4.70M

-71.0%

Short Term Debt

CA$12.77M

-36.7%

Return on Assets

-10.24%

N/A

Return on Invested Capital

-22.79%

N/A

Free Cash Flow

CA$1.76M

+994.1%

Operating Cash Flow

CA$1.79M

+1787.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ALSEAlseres Pharmaceuticals, Inc.
$0.01+100.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.92-0.28%
AALAmerican Airlines Group
$13.70-0.07%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.97-0.06%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$43.46+0.06%

Questions About LNDZF

What is the current price of Evome Medical Technologies?

Evome Medical Technologies is trading at $0.00 per share.

What is the 52-week range for Evome Medical Technologies?

Over the past 52 weeks, Evome Medical Technologies has traded between $0.00 and $0.01.

How much debt does Evome Medical Technologies have?

As of the most recent reporting period, Evome Medical Technologies reported total debt of CA$12.93M.

How much cash does Evome Medical Technologies have on hand?

Evome Medical Technologies reported CA$1.05M in cash and cash equivalents in its most recent financial results.

What is Evome Medical Technologies’s dividend yield?

Evome Medical Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services